Jee H Jung Selected Research

p-tyrosyl gallate

2/2008

Cytotoxicity of p-tyrosol and its derivatives may correlate with the inhibition of DNA replication initiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jee H Jung Research Topics

Disease

20	Neoplasms (Cancer) 07/2021 - 01/2004
7	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2012
6	Inflammation (Inflammations) 07/2021 - 01/2004
6	Carcinoma (Carcinomatosis) 10/2013 - 12/2007
5	Leukemia 11/2018 - 05/2004
2	Asthma (Bronchial Asthma) 11/2018 - 02/2016
2	Prostatic Neoplasms (Prostate Cancer) 12/2014 - 05/2011
2	Ovarian Neoplasms (Ovarian Cancer) 12/2012 - 08/2010
1	Weight Gain 03/2022
1	Obesity 03/2022
1	Neuroblastoma 07/2021
1	Wounds and Injuries (Trauma) 09/2020
1	Cushing Syndrome 01/2018
1	Parkinson Disease (Parkinson's Disease) 04/2017
1	Edema (Dropsy) 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Glioma (Gliomas) 02/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Colitis 10/2015
1	Respiratory Insufficiency (Respiratory Failure) 07/2015
1	Bacterial Infections (Bacterial Infection) 12/2014
1	Diabetes Complications 10/2013
1	Atopic Dermatitis (Atopic Eczema) 01/2013
1	Crohn Disease (Crohn's Disease) 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 02/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2010

Drug/Important Bio-Agent (IBA)

5	Histone Deacetylase InhibitorsIBA 12/2012 - 01/2008
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2022 - 10/2015
3	SirtuinsIBA 01/2016 - 09/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015 - 01/2014
3	Antineoplastic Agents (Antineoplastics)IBA 12/2014 - 05/2004
3	methyl jasmonateIBA 01/2013 - 09/2010
3	Histone Deacetylases (Histone Deacetylase)IBA 12/2012 - 01/2008
3	dideoxypetrosynol AIBA 01/2007 - 12/2004
2	LigandsIBA 03/2022 - 01/2018
2	viriditoxinIBA 08/2020 - 12/2014
2	TubulinIBA 08/2020 - 12/2014
2	OvalbuminIBA 11/2018 - 02/2016
2	CytokinesIBA 11/2018 - 01/2011
2	ResveratrolIBA 01/2017 - 01/2014
2	jasmonic acid (jasmonate)IBA 10/2015 - 01/2013
2	psammaplin AIBA 02/2015 - 01/2008
2	Cytochalasin BIBA 10/2013 - 05/2012
2	Tamoxifen FDA LinkGeneric 10/2012 - 01/2012
2	N1- hydroxy- N8- (4- phenoxyphenyl)octanediamideIBA 10/2012 - 08/2010
2	CaspasesIBA 02/2012 - 07/2005
2	FlavonoidsIBA 05/2011 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2011 - 12/2003
2	AcidsIBA 12/2008 - 01/2007
2	cynaropicrinIBA 05/2004 - 01/2004
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022
1	Rosiglitazone (Avandia)FDA Link 03/2022
1	cyclo-(L-Pro-L-Phe)IBA 07/2021
1	S-NitrosoglutathioneIBA 09/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2020
1	HydrogelsIBA 09/2020
1	Poloxamer (Poloxamer 407)IBA 09/2020
1	AlginatesIBA 09/2020
1	Antimitotic AgentsIBA 08/2020
1	MucinsIBA 11/2018
1	isoindoline-1,3-dioneIBA 11/2018
1	Mifepristone (RU 486)FDA Link 01/2018
1	SteroidsIBA 01/2018
1	Monoamine Oxidase (MAO)IBA 04/2017
1	CarrageenanIBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	4-(6-hydroxy-2-naphthyl)-1,3-benzenediolIBA 01/2017
1	Anti-Allergic Agents (Antiallergic Agents)IBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	2-hydroxyethyl 5-chloro-4,5-didehydrojasmonateIBA 10/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 07/2015
1	Biological ProductsIBA 02/2015
1	Proteins (Proteins, Gene)FDA Link 12/2014
1	anthraceneIBA 01/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014
1	fucosterolIBA 10/2013
1	Aldehyde Reductase (Aldose Reductase)IBA 10/2013
1	ChemokinesIBA 01/2013
1	Chemokine CCL22IBA 01/2013
1	apicidinIBA 12/2012
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2012
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 10/2012
1	Sirtuin 1IBA 09/2012
1	sirtinolIBA 09/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	Estrogen ReceptorsIBA 01/2012
1	MHY336IBA 05/2011
1	Topoisomerase II InhibitorsIBA 05/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2011
1	Peptides (Polypeptides)IBA 02/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2011
1	methyl 5-chloro-4,5-didehydrojasmonateIBA 09/2010
1	Hydroxamic Acids (Hydroxamic Acid)IBA 08/2010
1	Vorinostat FDA Link 08/2010

Therapy/Procedure

5	Therapeutics 08/2020 - 02/2011
1	Intraperitoneal Injections 01/2017
1	Drug Therapy (Chemotherapy) 08/2010
1	Aftercare (After-Treatment) 08/2010